Maintenance of glycaemic control with liraglutide versus oral antidiabetic drugs as add-on therapies in patients with type 2 diabetes uncontrolled with metformin alone: A randomized clinical trial in primary care (LIRA-PRIME).
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Maintenance of glycaemic control with liraglutide versus oral antidiabetic drugs as add-on therapies in patients with type 2 diabetes uncontrolled with metformin alone: A randomized clinical trial in primary care (LIRA-PRIME).
- Published In:
- Diabetes, obesity & metabolism, 24(2), 204-211 (2022)
- Authors:
- Unger, Jeff, Allison, Dale C, Kaltoft, Margit, Lakkole, Kavitha, Panda, Jayant K, Ramesh, Chethana, Sargin, Mehmet, Smolyarchuk, Elena, Twine, Melissa, Wolthers, Benjamin, Yarimbas, Gizem, Zoghbi, Marouan
- Database ID:
- RPEP-06555
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-06555APA
Unger, Jeff; Allison, Dale C; Kaltoft, Margit; Lakkole, Kavitha; Panda, Jayant K; Ramesh, Chethana; Sargin, Mehmet; Smolyarchuk, Elena; Twine, Melissa; Wolthers, Benjamin; Yarimbas, Gizem; Zoghbi, Marouan. (2022). Maintenance of glycaemic control with liraglutide versus oral antidiabetic drugs as add-on therapies in patients with type 2 diabetes uncontrolled with metformin alone: A randomized clinical trial in primary care (LIRA-PRIME).. Diabetes, obesity & metabolism, 24(2), 204-211. https://doi.org/10.1111/dom.14566
MLA
Unger, Jeff, et al. "Maintenance of glycaemic control with liraglutide versus oral antidiabetic drugs as add-on therapies in patients with type 2 diabetes uncontrolled with metformin alone: A randomized clinical trial in primary care (LIRA-PRIME).." Diabetes, 2022. https://doi.org/10.1111/dom.14566
RethinkPeptides
RethinkPeptides Research Database. "Maintenance of glycaemic control with liraglutide versus ora..." RPEP-06555. Retrieved from https://rethinkpeptides.com/research/unger-2022-maintenance-of-glycaemic-control
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.